Showing results (21-30 of 990) with videos related to
Sort By:
Pageof 99
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 29, 2010
Randomized phase II trials: time for a new era in clinical trial designSumithra J Mandrekar, Daniel J SargentJournal of the National Cancer Institute|November 4, 2010
Designing a randomized clinical trial to evaluate personalized medicine: a new approach based on risk predictionStuart G Baker, Daniel J SargentChinese Clinical Oncology|January 8, 2017
Findings from the Adjuvant Colon Cancer End Points (ACCENT) Collaborative Group: the power of pooled individual patient data from multiple clinical trialsLindsay A Renfro, Daniel J SargentJournal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 3, 2011
All-comers versus enrichment design strategy in phase II trialsSumithra J Mandrekar, Daniel J SargentClinical Investigation|March 6, 2012
Design of clinical trials for biomarker research in oncologySumithra J Mandrekar, Daniel J SargentJournal of Biopharmaceutical Statistics|April 23, 2009
Clinical trial designs for predictive biomarker validation: one size does not fit allSumithra J Mandrekar, Daniel J SargentEuropean Journal of Cancer (Oxford, England : 1990)|December 9, 2008
Optimising the design of phase II oncology trials: the importance of randomisationMark J Ratain, Daniel J SargentJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2009
Clinical trial designs for predictive biomarker validation: theoretical considerations and practical challengesSumithra J Mandrekar, Daniel J SargentJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 5, 2011
Alternative end points to evaluate a therapeutic strategy in advanced colorectal cancer: evaluation of progression-free survival, duration of disease control, and time to failure of strategy--an Aide et Recherche en Cancerologie Digestive Group StudyBenoist Chibaudel, Franck Bonnetain, Qian Shi, et al.Statistics in Medicine|October 13, 2005
An adaptive dose-finding design incorporating both toxicity and efficacyWei Zhang, Daniel J Sargent, Sumithra MandrekarPageof 99